Preparation of Internally Labelled Rat Pituitary Somatotropin (Growth Hormone) By MICHAEL WALLIS, RICHARD V. DAVIES* and MARGARET DANIELS School ofBiological Sciences, University of Sussex, Falmer, Brighton BNI 9QG, Sussex, U.K. (Received 16 August 1977) Rat somatotropin (growth hormone) was labelled biosynthetically by incubating anterior pituitary lobes with radioactive amino acids for 24h in a simple buffered salts medium containing glucose. The labelled hormone was isolated by preparative polyacrylamide-gel electrophoresis or by chromatography on Sephadex G-100 and then DEAE-cellulose. The labelled material was pure by several criteria and cross-reacted immunologically with unlabelled rat somatotropin. When a mixture of 14C-labelled amino acids was used for labelling the protein, label could be introduced into these same amino acids of somatotropin, though relative specific radioactivities varied considerably. Somatotropin labelled by the procedures described in the present paper was suitable for structural studies and could be used for a variety of other biochemical experiments.
When the rat anterior pituitary gland is incubated in vitro in a simple buffered salts solution containing glucose and a labelled amino acid, label is incorporated into pituitary proteins, including somatotropin (growth hormone) and prolactin. This system has been used extensively to study the biosynthesis of such pituitary hormones and its regulation (e.g. MacLeod & Abad, 1968; Betteridge & Wallis, 1973) . The amount of label incorporated is sufficient to allow the possibility of preparing internally labelled proteins for use in various biochemical systems. Catt & Moffat (1967) used such an approach to prepare labelled prolactin.
We have explored the possibility of preparing labelled rat somatotropin by this method, with the intention of producing sufficient material for structural studies. Amino acid-sequence studies have been carried out on somatotropins from various mammnalian species, but so far these have been mnainly large domestic animals (and man). Structural studies on pituitary hormnones from smaller animals are limited by shortage of material. If somatotropin that was labelled in several or all amino acids could be prepared, it should be possible to use this for sequence studies, detecting peptides, amino acids and their derivatives by virtue of their radioactivity and thereby greatly increasing the sensitivity of detection. The studies described here were designed to explore the possibility of producing labelled somatotropin suitable for such structural studies, though such material may be useful for other purposes also. U.K.) and was washed before use as recommended by the manufacturers. Ampholine was from LKB Instruments (South Croydon, Surrey, U.K.). Trasylol was from Bayer (U.K.) (Haywards Heath, West Sussex, U.K.).
Animals
Pituitary glands were obtained from male rats (150-200g) of the albino Sprague-Dawley strain. These animals were obtained from the laboratory colony and were fed ad lib.
Incubation ofpituitary glands
Rats were killed by cervical dislocation and the pituitary glands were removed. Anterior and posterior lobes were separated, and the former were placed in medium at room temperature (about 20°C). Media for incubation were tissue-culture medium 199 (Morgan et al., 1950) , Gey & Gey's (1936) & Wallis, 1973) . These media were equilibrated with C02/air (1:19) before use, and during incubations, and contained glucose (11.2mM), Phenol Red (20pg/ml), penicillin (35,ug/ ml) and streptomycin (100,ug/ml), and in some cases bovine serum albumin (1mg/ml). Pituitary glands were divided into halves and rinsed in medium before incubation. They were incubated at 370C under CO2/air (1: 19).
After incubation, pituitary glands and media were separated. Most of the subsequent work was carried out on the glands, which contained the bulk of the labelled somatotropin, but in some cases the media were also analysed. Glands were homogenized in NH4HCO3/(NH4)2CO3 buffer (0.2M-NH4HCO3 adjusted to pH8.5 with aq. NH3).
Analytical polyacrylamide-gel electrophoresis
For analytical-scale fractionation of pituitary extracts and column eluates, analytical gels of the type described by Davis (1964) were used. These were formed by polymerization of 8.0 % (w/v) acrylamide and 0.2% (w/v) methylenebisacrylamide in glass tubes of internal diameter 6mm. A discontinuous buffer system was used (Davis, 1964) Isoelectric focusing in polyacrylamide gels Analytical-scale isoelectric focusing was carried out in polyacrylamide gels (Wrigley, 1968) Column chromatography Purification of small quantities of labelled rat somatotropin wag carried out by gel filtration and subsequent ion-exchange chromatography. Chromatography was performed at 4°C and eluants contained 0.03% toluene as a bacteriostat. Gel filtration was on columns (approx. 45cm x 0.28cm2) of Sephadex G-100, equilibrated with 0.02M-Tris/HCl buffer, pH8.5. Ion-exchange chroinatography was carried out on small columns (2-5cm x 0.28 cm2) of DEAEcellulose (Whatman DE-32) equilibrated with 0.02M-Tris/HCl buffer, pH 8.5. Samples were applied in this buffer and were then eluted by a linear 0-0.1 M-NaCl gradient prepared by mixing 40ml of starting buffer and 40ml of 0.1 M-NaCl in the Tris buffer. In most cases the column was then also eluted with steps of 0.2M-and 2M-NaCl in the starting buffer (about 25 ml in each case). Fractions were collected in polystyrene tubes to minimize adsorption of labelled protein. Radioactivity in these fractions was determined by scintillation counting, as described under 'Analytical polyacrylamide-gel electrophoresis'.
Amino acid analysis
For amino acid analysis, samples of labelled rat somatotropin were hydrolysed with 6M-HCI in a sealed evacuated tube at 110°C for 24h. Before hydrolysis, samples were mixed with unlabelled bovine somatotropin (1-2mg) and desalted by chromatography on Sephadex G-25. The distribution of radioactivity in the amino acids of the hydrolysate was determined by using an amino acid analyser (Locarte Co., London W12 9RT, U.K.) linked to a flow scintillation counter (Tracerlab, Weybridge, Surrey, U.K.). Counting efficiency for 14C in this system was 30-35 %. In some cases amnino acids were fractionated by paper electrophoresis and chromatography.
The relative specific radioactivities of the amino acids in the labelled hormone were determined by dividing the d.p.m. associated with each amino acid in an analysis by the number of residues of that amino acid in rat somatotropin (as given by Ellis et al., 1968) .
Interaction oflabelled rat somatotropin with antiserum to somatotropin
The antiserum was obtained freeze-dried, and was reconstituted (to 10% serum) in diluent buffer containing 1 % (w/v) bovine serum albumin, 0.1 % (w/v) Vol. 169 sodium azide, 0.15M-NaCl, 0.01 M-NaH2PO4 and 0.02M-EDTA, adjusted to pH7.6 with NaOH. A portion (0.1 ml) of this antiserum was incubated with labelled rat somatotropin, with or without 300ug of unlabelled rat somatotropin, for 16h at 4°C. Trasylol (a proteinase inhibitor; r1oul of a 2.8 mg/ml solution) was included in each incubation. The mixtures were then submitted to gel filtration on a column (approx. 45 cmx0.28cm2) of Sephadex G-100, under the conditions given above.
Sequence analysis with rat somatotropin labelled with [35S]methionine
A Beckman sequencer (model 890; Beckman Instruments, Glenrothes, Fife, Scotland) was used, with the dimethylbenzylamine programme of Hermodson et al. (1972) . Reagents for the sequencer were obtained from Beckman Instruments, or from Pierce Chemical Co. (Chester, U.K.).
Radioimmunoassay ofrat somatotropin
Radioimnmunoassay of rat somatotropin was carried out with a kit obtained from the National Institute of Arthritis, Metabolism and Digestive Diseases (Bethesda, MD, U.S.A.). The procedure was that described in the instructions accomnpanying the reagents, except that precipitation of antibodyhormone complex was carried out by using poly-(ethylene glycol), as described by Desbuquois & Aurbach (1971) .
Results

Incorporation oflabelledamino acids into somatotropin
When anterior pituitary lobes were incubated in vitro with labelled amino acids, label was incorporated into pituitary proteins, including sornatotropin (Fig. 1) . Incorporation into this hormone was approximately linear with time for 24h in simple incubation mnedia (Krebs-Ringer bicarbonate buffer with added glucose; Gey & Gey's medium), but subsequently slowed considerably. In tissue-culture medium 199, incorporation into somatotropin continued for much longer periods (up to 72h), but the total amount of radioactivity incorporated was decreased, presumably because the amino acids in the medium diluted out the added label.
Various attempts were made to increase the overall incorporation of labelled amino acids into somatotropin, by using alternative incubation media, or supplementing the incubations with various factors. (Fig. 3) . Polyacrylamide-gel electrothe ri(hto phoresis demonstrated that the main peak eluted by theright, *the NaCl gradient (peak I) contained somnatotropin (Fig. 4) . Material eluted by 0.2M-NaCl from the DEAE-cellulose columnn (peak II in Fig. 3 Fraction no. Fig. 3 . Chromatography on DEAE-cellulose ofthe somatotropin-containing peak from a Sephadex G-100 column Peak B from the column shown in Fig. 2 Characterization oflabelled rat somatotropin The homogeneity of the material believed to be labelled somnatotropin (peak I, Fig. 3 ) was studied by analytical polyacrylatide-gel electrophoresis (Fig. 4) and isoelectric focusing (Fig. 5) . In each case the material from the peak tube (tube 31) and the leading edge (tube 28) showed a single peak corresponding to the mnain component of the rat somatotropin marker. The trailing edge of the peak (tube 37) showed some labelled material running faster than this marker on electrophoresis, and with a slightly lower isoelectric point on isoelectric focusing. This may represent deamidated somatotropin; it can be excluded readily by pooling the mnaterial in peak I without the tail of the peak. Peak II from DEAE-cellulose contained no material in the position of the rat somatotropin marker on polyacrylamide-gel electrophoresis.
Rechromatography of labelled rat somatotropin (peak I from DEAE-cellulose) on Sephadex G-100, under the conditions shown in Fig. 2 and with 0.2mg of bovine somatotropin as carrier, showed a single peak of radioactivity running in the position of peak B in Fig. 2 , which is that expected for a somatotropin. Rechromatography of the labelled hormone on DEAE-cellulose, under the conditions shown in Fig. 3 and with 1.0mg of unlabelled rat somatotropin as carrier, gave a single peak of radioactivity running in the position of peak I in Fig. 3 (Fig. 3) were submitted to analytical polyacrylamide-gel electrophoresis, with 20ug of unlabelled rat somatotropin as carrier. Gels were sliced (2mm) and solubilized for determination of radioactivity. The arrow shows the position of the main band of carrier somatotropin, seen on the stained gels (pattern as in Fig. 1 Antiserum to rat somatotropin was used to demonstrate the immunological similarity of the labelled material to rat somatotropin. The Distance along gel (cm) Fig. 5 . Isoelectric focusing oflabelled rat somatotropin Labelled rat somatotropin (peak I, Fig. 3 was incubated for 16h with the antiserum in the presence or absence of 300,ug of unlabelled rat somatotropin, and the mixtures were then chromatographed on Sephadex G-100. Results are shown in Fig. 6 . In the absence of unlabelled somatotropin, radioactivity was eluted from the column in a fastrunning peak (X) at the void volume of the column, whereas in the presence of an excess of unlabelled hormone, nearly all of the radioactivity ran in the position expected for somatotropin (peak Y). We conclude that the antiserum binds the labelled hormone, and that an excess of unlabelled hormone can displace the labelled material.
The distribution of labelled amino acids in the radioactive somatotropin was investigated after hydrolysis, as described in the Materials and Methods section. Label was found in all types of amino acids ofthe hormone, provided that these had been included in the incubation medium. The relative specific radioactivities of the amino acids in the labelled hormone varied considerably, those of phenylalanine, leucine, isoleucine and valine generally being high and those of glycine, alanine, proline and serine low. The relative specific radioactivities of several amnino acids, especially aspartic acid and glutamic acid, were variable from one experiment to another. The reason for this is not clear and its interpretation is complicated by the fact that asparagine and glutamine were converted into the corresponding acids during hydrolysis. Batches of labelled hormone made by both the electrophoretic and chromatographic methods were used for these experiments and did not appear to differ significantly.
The identity and homogeneity of the labelled rat somatotropin was further demonstrated by amino acid-sequence studies. Fig. 7 ionine in Krebs-Ringer bicarbonate medium with added glucose for 24h. The hormone was then purified from the pituitary homogenate by chromatography on Sephadex G-100 and DEAE-cellulose, and desalted on a column ofSephadex G-25 (medium) equilibrated with 1 mM-acetic acid (with 1 mg of bovine serum albumin as carrier). A sample (33 nCi) of the labelled hormone was subjected to sequence analysis with 5mg of apomyoglobin. Samples from the sequenator were extracted as usual, and one half ofeach extract was submitted to scintillation counting [after mixing with scintillation mixture containing 0.35%o 2,5-diphenyloxazole and 0.005%/ 1,4-bis-(4-methyl-5-phenyloxazol-2-yl)benzene in toluene]. The remainder of the extract was submitted to t.l.c. to confirm that the phenylthiohydantoins expected during the Edman degradation of myoglobin were obtained.
protein (Wallis & Davies, 1976) . Further sequence studies on labelled hormone (prepared by preparative polyacrylamide electrophoresis) have confirmned its identity and homogeneity (Wallis & Davies, 1976 , and unpublished work).
Specific radioactivity of labelled rat somatotropin
The specific radioactivity of the labelled rat somnatotropin prepared in the experiment illustrated in Fig. 3 was determined by using radioimmunoassay to determine the somatotropin concentration in peak I. The specific radioactivity of this material Vol. 169 was 2.4nCi/,ug. This value is probably an underestirnate, since the rat somatotropin used as a standard in the assay (NIAMDD-Rat GH-RP-1) is rather impure, and the content of somatotropin estimnated in peak I is therefore an overestimate.
Discussion
It is evident that labelled rat somatotropin can be prepared by biosynthesis in vitro in quantities sufficient for use in biochemnical experiments. Yields in the chromatographic steps were reasonably high, and losses caused by adsorption on glass, chromatographic mnedia etc. were apparently not excessive. However, attempts to rechromatograph trace quantities of the labelled hormone in these systems in the absence of carrier material did give very poor recoveries, presumably due to such adsorption, and this may limit the extent to which the method can be scaled down.
The identification of the labelled material as somatotropin is based on comparison with a sample of unlabelled hormone in various separation systems, its specific association with antiserum to rat somatotropin and on sequence studies. Identification by conventional biological assay was not possible, since the amount of material present was insufficient. The labelled hormone was homogeneous by several criteria, and showed less sign of microheterogeneity than the unlabelled rat somatotropin preparation available (and indeed most somatotropin preparations available from other species).
The specific radioactivity of somatotropin labelled with "IC-labelled amino acids is of course very low (about 2.4nCi/,ug). It is possible that altered incubation conditions may increase this value somewhat, but since the specific radioactivity of the 'IC-labelled amino acids used cannot be significantly increased, that of the product is also limited. Material of higher specific radioactivity can be prepared if 3H-labelled amino acids are used (or [35S] methionine and/or [35S]cysteine), though cost eventually becomes a limiting factor. However, internally labelled somatotropin was prepared in this study primarily for structural studies, and for these the absolute amount of radioactivity incorporated is more important than the specific radioactivity of the product.
A more serious problem than low specific radioactivity for the present purposes is the marked variation in the specific radioactivities of different amino acids within the labelled protein. The specific radioactivities of the most heavily labelled amino acids (including phenylalanine, leucine, iwleucine and valine) were 10-30 times those ofthe least heavily labelled (such as glycine, alanine, serine and proline). If the protein is to be used for amino acid-sequence studies, the specific radioactivity of the least heavily labelled amino acids will become limiting, and this therefore presents a considerable problem. The reasons for the differences in specific radioactivities for different amino acids have not been determined in detail, but they probably include differences in specific radioactivity of labelled amino acids added (in most cases a function of the number of carbon atoms in each amino acid), differences in amounts of labelled amino acids added, different pool sizes for different amino acids in the pituitary and different extents of metabolism of the different amino acids.
Several authors have proposed that amino acids utilized for protein synthesis in mammalian tissues do not pass through the general amino acid pool of the cell (Hider et al., 1969; Samli et al., 1971) . However, it is clear that in the present study the relative specific radioactivities of the amino acids in labelled somatotropin are not correlated with the specific radioactivities or the total quantities oflabelled amino acids in the incubation mixture. Metabolism ofamino acids was certainly occurring during these incubations, since amino acid analysis showed that the distribution of label among free amino acids after incubation was markedly different from the initial distribution, both in the incubation medium and in the pituitary homogenate. The detailed nature of such amino acid metabolism has not been investigated yet; information about it might well suggest ways of increasing the specific radioactivity of those amino acids least heavily labelled.
Despite the problems incurred owing to the incorporation of some amino acids at low specific radioactivities, it seems likely that the labelled somatotropin prepared by the method described here will be useful for various types of biochemnical study. We have shown (Wallis & Davies, 1976 ) that such material can be used for studies on the amino acid sequence of rat somatotropin, and these studies are continuing. Others have also used internally labelled proteins for sequence studies (Jacobs et al., 1974; McKean et al., 1974) , and it is clear that many variations of the labelling and sequencing techniques can be used.
Internally labelled somatotropin should be useful for a variety of other biochemical purposes, including studies on the degradation of the hormone and on binding to tissues, cells and membrane receptors in vivo and in vitro. In most previous studies of this type protein hormnones have been labelled with radioactive iodine (by iodination primarily of tyrosine residues); such an approach has disadvantages in that the iodine may be removed from the hormone, the iodinated hormone may behave differently from the natural .ne and any derivatives produced from the hormone that do not contain iodinated tyrosine will not be labelled and therefore cannot be traced.
Clearly, material produced by biosynthesis does not have these disadvantages, and the fact that the position of the label can be varied according to the nature of the amino acid used may have advantages in the location and identification of specific degradation products. On the other hand, the specific radioactivity of labelled somatotropin prepared biosynthetically is as yet much too low to replace iodinated hormone in many types of study.
Labelling of somatotropin by biosynthesis is a particularly favoured case because this hormone represents a high proportion of the total protein synthesized in the male rat pituitary gland (Fig. 1) . Whether this method can be applied generally to the preparation of other labelled hormones, and indeed other animal proteins, will depend partly on whether other preparations can be found that make the required protein as a high proportion of the total protein synthesized. In many cases this should be possible. Thus, in the pituitary, use of female glands (in mammals) should enable application of the approach to the preparation of labelled prolactin (Catt & Moffat, 1967) . For other pituitary hormones it may be necessary to carry out a partial separation of the appropriate hormone-secreting cells before biosynthetic labelling is attempted.
